TRPA1 and peripheral neuropathy: Recent evidence suggests that TRPA1 is implicated in developing chemotherapeutic-induced peripheral neuropathy (CIPN), mediating the mechanical and cold hypersensitivity provoked by platinum-based anticancer drugs [44].